Harry Paul, Principal, Milltrust Ventures
Harry Paul is a life science investor with over 30 years of executive experience in the sector. He has held several international commercial and management roles at Roche and Boston Scientific and most recently served as the CEO of Tharos, an animal health start-up specialising in gut microbiome research. Additionally, he runs his own consulting company, advising health sector companies on international business development. Beyond his expertise in life science, Harry has also invested in agriculture in Latin America and has played a pivotal role in developing several investment projects in the region. He collaborated closely with Milltrust on their agricultural assignments in Latin America from 2013 to 2015. A keen linguist, Harry is proficient in Spanish, Portuguese, French, and Italian. He holds a degree in Genetics and Microbiology from Leeds University.